APstem Therapeutics, Inc.
company
About
NOVEL STEM CELL TECHNOLOGY TARGETING UNMET MEDICAL NEEDS
- 1 - 10
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- $2.80M
- Industries
- Biotechnology,Health Care,Life Science
- Founded date
- Jan 1, 2017
- Number Of Employee
- 1 - 10
- Operating Status
- Active
With APstem Therapeutics’ breakthrough discovery of Adult Pluripotent Stem Cells (APSCs™), we are on a mission to eradicate difficult-to-heal diseases and conquer the challenges of aging.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$4.30M
APstem Therapeutics, Inc. has raised a total of
$4.30M
in funding over 2 rounds. Their latest funding was raised on
Sep 1, 2020 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 1, 2020 | Seed | $2.80M | 1 | — | — | Detail |
| May 1, 2019 | Seed | $500K | 1 | — | — | Detail |
| Aug 1, 2018 | Seed | $1M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
APstem Therapeutics, Inc. is funded by 1 investors.
Magic Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Magic Capital
|
— | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
